statements

GKB Ophthalmics Ltd.

BSE: 533212

Sector: Healthcare

Industry Group: Healthcare Equipment & Supplies

Industry: Medical Equipment & Supplies

58.39+2.4 (+4.29%)

7 Aug, 12:00 AM

Overview Analysis Statements

Technicals Forecast Peers Resources News

Income Statement

Abridged

Understanding Income Statement

GKB Ophthalmics Ltd. income statement covering revenue, operating profit, EBITDA, PAT and EPS across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	C 2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	R 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR
EPS - Basic - ex Extraordinary Items	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Operating Revenue	24.83	32.65	22.28	19.78	28.72	51.44	53.98	39.11	40.72	40.20	47.52	50.23	62.64	76.53	108.63
EPS - Diluted - ex Extraordinary Items	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBIT	6.00	1.95	6.35	-0.71	-3.23	0.45	-0.36	-2.39	-1.56	-1.22	2.18	0.86	-2.32	-5.87	5.32
EBITDA	6.87	3.13	7.57	0.84	-1.74	1.88	1.34	1.14	2.06	1.92	4.85	3.69	0.58	-2.78	8.56
EBITDA Margin	17.7	7.3	18.3	2.4	-4.0	2.5	1.7	2.0	3.5	3.4	6.8	4.9	0.7	-2.6	5.7
Supplementary
Financing Income/(Expense) - Net	-2.49	-2.63	-2.83	-2.08	-1.44	-1.29	-1.27	-1.48	-1.46	-2.03	-1.27	-1.07	-1.01	-1.30	-2.67
Gross Profit	13.90	10.15	19.17	15.40	15.04	25.00	23.95	18.05	17.73	16.68	23.42	25.24	25.62	32.45	40.43
Gross Margin	35.9	23.7	46.3	43.8	34.4	32.7	30.7	31.6	30.3	29.3	33.0	33.4	29.0	29.8	27.1
Profit before Taxes	4.04	-1.22	4.58	-2.08	7.90	2.94	-1.14	-1.58	-2.45	-1.55	1.85	0.11	-2.72	-6.91	3.10
Profit after Tax	3.08	-0.62	3.99	0.00	3.95	2.59	-0.97	-1.10	-1.84	-0.91	1.27	-0.17	-2.81	-7.04	1.22
PAT Margin	8.0	-1.5	9.6	-	9.0	3.4	-1.2	-1.9	-3.1	-1.6	1.8	-0.2	-3.2	-6.5	0.8
Total Operating Expenses	32.73	40.85	35.10	35.89	46.99	76.00	78.29	59.55	60.02	58.10	68.76	74.62	90.57	114.86	-
Operating Profit	6.00	1.95	6.35	-0.71	-3.23	0.45	-0.36	-2.39	-1.56	-1.22	2.18	0.86	-2.32	-5.87	-
Operating Margin	15.5	4.6	15.3	-2.0	-7.4	0.6	-0.5	-4.2	-2.7	-2.2	3.1	1.1	-2.6	-5.4	-
Income Taxes	0.81	-0.13	2.11	-0.77	3.95	0.36	-0.17	-0.48	-	-0.18	0.00	0.02	0.21	0.35	0.08
Total Revenue	38.73	42.80	41.45	35.18	43.76	76.44	77.93	57.16	58.45	56.88	70.94	75.47	88.25	108.99	149.06

Balance Sheet

Abridged

Understanding Balance Sheet

GKB Ophthalmics Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	C 2016 Mar 31	C 2017 Mar 31	C 2018 Mar 31	C 2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Source:	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR
Total Assets	70.82	72.78	72.84	74.97	69.21	81.77	82.98	93.43	102.25	106.82	110.16	112.27	114.50	125.21	132.17
Total Shareholders' Equity	35.27	34.96	39.90	40.01	44.81	46.79	44.94	54.81	59.25	62.65	63.10	62.69	59.77	52.04	52.83
Total Current Liabilities	31.31	34.27	30.11	33.30	22.70	33.12	36.41	37.15	41.38	38.12	39.64	41.27	46.23	62.39	71.19
Accumulated Depreciation & Impairment	11.16	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Long-Term Investments	0.00	12.37	15.06	16.25	4.34	0.00	0.00	0.58	1.23	1.80	2.00	1.96	1.84	2.06	2.02
Total Non-Current Liabilities	4.24	3.54	2.83	1.67	1.70	1.86	1.63	1.48	1.62	2.40	3.10	3.70	4.07	6.39	6.09
Long Term Debt	3.02	2.45	1.52	0.48	0.13	0.07	0.02	-	-	1.00	1.62	1.17	1.05	3.08	1.57
Minority Interest	-	-	-	-	-	-	-	-	-	3.65	4.32	4.60	4.43	4.40	2.05
Property Plant & Equipment - Gross	25.49	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Property Plant & Equipment - Net	14.33	14.86	14.30	12.37	13.17	17.39	17.83	25.10	25.58	24.24	26.06	22.98	22.12	20.94	18.61
Total Liabilities & Equity	70.82	72.78	72.84	74.97	69.21	81.77	82.98	93.43	102.25	106.82	110.16	112.27	114.50	125.21	132.17
Total Current Assets	44.31	45.42	43.36	45.88	51.16	62.65	63.82	63.93	72.76	74.00	75.53	83.53	87.48	99.39	107.96
Total Non-Current Assets	26.51	27.36	29.47	29.09	18.04	19.12	19.16	29.50	29.49	32.82	34.62	28.73	27.02	25.82	24.21
Total Liabilities	35.55	37.82	32.94	34.96	24.40	34.99	38.04	38.63	43.00	40.52	42.74	44.97	50.30	68.78	77.28
Total Equity	35.27	34.96	39.90	40.01	44.81	46.79	44.94	54.81	59.25	66.30	67.42	67.30	64.20	56.44	54.89

Cash Flow

Abridged

Understanding Cash Flow Statement

GKB Ophthalmics Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	C 2017 Mar 31	2018 Mar 31	C 2019 Mar 31	R 2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR
Capital Expenditures - Net	5.25	1.56	0.86	0.65	1.99	5.98	1.86	9.97	3.75	5.99	4.63	-0.54	2.03	2.11	0.90
Dividends Paid - Cash - Total	0.00	0.01	-	-	-	-	-	-	-	-	-	0.00	-	-	-
Capital Expenditures - Gross	5.28	1.56	0.93	0.66	3.16	6.32	1.88	13.20	3.86	6.33	4.76	1.66	2.08	2.15	1.03
Working Capital - Increase/(Decrease)	-4.39	0.87	-1.42	6.95	-4.93	-5.29	-5.08	1.56	0.17	-6.00	-0.32	-6.64	3.28	-5.93	-11.27
Free Cash Flow to Equity	0.13	0.79	0.98	0.72	-15.46	-10.37	-3.06	-3.24	-0.81	-14.83	-1.11	-4.33	2.43	-3.97	-8.90
Free Operating CF	-3.52	-0.66	3.48	4.60	-15.23	-10.68	-5.72	-10.61	-2.02	-11.97	-1.02	-5.99	2.11	-7.02	-6.19
Free Operating CF net dividend	-3.52	-0.66	3.48	4.60	-15.23	-10.68	-5.72	-10.61	-2.02	-11.97	-1.02	-5.99	2.11	-7.02	-6.19
Operating CF bef Changes in Working Cap	6.16	0.03	5.84	-1.69	-7.14	0.94	1.24	1.02	1.68	0.36	4.06	2.31	0.91	1.05	7.47
Debt - LT & ST - Issuance/(Retirement) - Total	3.62	1.45	-2.58	-3.89	-1.39	-0.04	2.64	4.14	1.09	-3.20	-0.22	-0.54	0.27	3.01	-2.84
Stock - Issuance/(Retirement) - Net	-	-	-	-	-	-	-	10.45	4.65	7.98	-	-	-	-	-
Net Cash Flow from Financing Activities	3.62	1.44	-2.58	-3.89	-1.39	-0.04	2.64	14.60	5.74	4.77	-0.22	-0.54	0.27	3.01	-2.84
Net CF from Investing Activities	-5.36	-1.54	-2.16	-0.65	13.87	3.41	1.25	-10.02	-3.75	-6.29	-3.64	1.34	-3.59	1.65	7.65
Net CF from Operating Activities	1.76	0.90	4.42	5.26	-12.07	-4.36	-3.84	2.59	1.84	-5.63	3.74	-4.33	4.19	-4.87	-5.16

Business Segment Analysis

GKB Ophthalmics Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

We don't have enough data to show business segment analysis for GKB Ophthalmics Ltd.

Regional Segment Analysis

FY End:

Mar 12

GKB Ophthalmics Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

Revenue / Sales

Outside India (73.6%)₹ 28.37 CrIndia (26.4%)₹ 10.17 Cr

Historical Segment Analysis

Track how GKB Ophthalmics Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

Sales

Business

Regional

Business

We don't have enough data to show the Capex for GKB Ophthalmics Ltd..

Frequently Asked Questions

What is the revenue of GKB Ophthalmics Ltd.?

The latest trailing twelve month revenue of GKB Ophthalmics Ltd. is ₹ 149.06 Cr, reflecting a 1-year growth of 36.77% and a 3-year CAGR of 25.47%. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of GKB Ophthalmics Ltd.?

The latest trailing twelve month net profit (PAT) of GKB Ophthalmics Ltd. is ₹ 1.22 Cr. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of GKB Ophthalmics Ltd.?

The trailing twelve month EBITDA of GKB Ophthalmics Ltd. is approximately ₹ 5.38 Cr (based on an operating margin of 3.61%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.

What is the EPS of GKB Ophthalmics Ltd.?

The trailing twelve month Earnings Per Share (EPS) of GKB Ophthalmics Ltd. is 2.42. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of GKB Ophthalmics Ltd.?

The debt-to-equity ratio of GKB Ophthalmics Ltd. stands at 0.22. The interest coverage ratio is 2.01x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of GKB Ophthalmics Ltd.?

The estimated book value per share of GKB Ophthalmics Ltd. is 104.81 (derived from a P/B ratio of 0.56 and market price of ₹ 58.39), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.

What is the cash flow from operations of GKB Ophthalmics Ltd.?

The trailing twelve month operating cash flow of GKB Ophthalmics Ltd. is ₹ -5.16 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does GKB Ophthalmics Ltd. report consolidated or standalone financials?

GKB Ophthalmics Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.